Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GCP-003 (gPhe-HMRG) is an activatable fluorescent probe developed by GORYO Chemical in collaboration with Solasia Pharma for the intraoperative detection of postoperative pancreatic juice leakage (pancreatic fistula). The probe is based on the hydroxymethyl rhodamine green (HMRG) fluorophore, which is initially non-fluorescent. Upon contact with pancreatic juice, the probe is enzymatically activated by chymotrypsin (the active form of chymotrypsinogen), resulting in a rapid increase in fluorescence. This allows surgeons to identify leakage sites in real-time during surgery, potentially reducing the incidence and severity of complications following pancreatic resection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GCP-003.